Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-529-5 | CAS number: 1471313-51-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: compliance to GLP and test guideline; coherence between data, results and conclusion
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian cell gene mutation assay
Test material
- Reference substance name:
- Sodium 2-[methyloleoylamino]ethane-1-sulphonate
- EC Number:
- 205-285-7
- EC Name:
- Sodium 2-[methyloleoylamino]ethane-1-sulphonate
- Cas Number:
- 137-20-2
- Molecular formula:
- C21H41NO4S.Na
- IUPAC Name:
- sodium 2-[methyl(oleoyl)amino]ethanesulfonate
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- - Appereance supplied by the Sponsor: yellowish pale powder
- Description at first use: yellowish powder
- Storage condition of test material: room temperature
Constituent 1
Method
- Target gene:
- hypoxanthine-guaninphosphoribosyl-transferase (HPRT)
Species / strain
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- - Type and identity of media:
EMEM Minimal Medium
EMEM Complete Medium (10% Fetal Bovine Serum)
DMEM Minimal Medium
DMEM Complete Medium (10% Fetal Bovine Serum)
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically "cleansed" against high spontaneous background: yes - Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- Liver S9 fraction from rats induced with phenobarbitone and beta-naphthoflavone (Mixed Induction).
- Test concentrations with justification for top dose:
- Experiments without S9 mix:
32.3, 23.1, 16.5, 11.8, 8.40 and 6.00 ug/mL for the first experiment
28.2, 21.7, 16.7, 12.8 and 9.87 ug/mL for the second experiment
Experiments with S9 mix:
600, 462, 355, 273, 210 and 162 ug/mL for the first experiment
500, 458, 382, 318 and 265 ug/mL for the second experiment - Vehicle / solvent:
- Minimal Culture Medium.
Controlsopen allclose all
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9,10-dimethylbenzanthracene
- Remarks:
- with S9 mix
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- ethylmethanesulphonate
- Remarks:
- without S9 mix
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium;
DURATION
- Exposure duration: 3 hours in the absence and presence of S9 metabolism
- Expression time (cells in growth medium): day 6 and day 9
- Selection time (if incubation with a selection agent): 10-15 days
SELECTION AGENT (mutation assays): 6 -thioguanine
STAIN: Giemsa
NUMBER OF REPLICATIONS: Two replicate cultures for each experimental point; two indipendent mutation experiments
NUMBER OF CELLS EVALUATED: 1x10^5 cells/ 100 mm tissue culture petri dishes (five plates, a total of 5 x10^5 cells)
DETERMINATION OF CYTOTOXICITY
- Method: cloning efficiency; relative cloning efficiency;
DETERMINATION OF MUTATION
- Method: Induced mutant frequency - Evaluation criteria:
- For a test item to be considered mutagenic in this assay, it is required that:
(i) There is a five-fold (or more) increase in mutation frequency compared with the solvent controls, over two consecutive doses of the test item. If only the highest practicable dose level (or the highest dose level not to cause unacceptable toxicity) gives such an increase, then a single treatment-level will suffice.
(ii) There must be evidence for a dose-relation (i.e. statistically significant effect in the ANOVA analysis).
The “five-fold increase” in mutant frequency above the concurrent negative control is used as arbitrary criteria for positive response and it was established in our laboratory based on analysis of variation of negative control data.
If spontaneous mutation frequency is in the upper part of the historical range, significance of mutation increase is evaluated case by case.
Historical control data are used to demonstrate biological relevance of the results obtained. - Statistics:
- ANOVA analysis for effect of replicate culture, expression time and dose level
Results and discussion
Test results
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
No precipitation of the test item was noted upon addition of the test item to the culture in all treatment series and by the end of treatment incubation period.
The addition of the test item solution did not have any obvious effect on the osmolality or pH of the treatment medium.
RANGE-FINDING/SCREENING STUDIES:
Two preliminary cytotoxicity assays were performed.
In the first experiment the test item was assayed at a maximum dose level of 5000 g/mL and at a wide range of lower dose levels: 2500, 1250, 625, 313, 156, 78.1, 39.1 and 19.5 µg/mL. In the absence of S9 metabolism, no cell survived after treatment at the seventh highest dose levels, while marked toxicity was noted at 39.1 µg/mL reducing survival to 16% of the negative control value. In the presence of S9 metabolism, no cell survived at the three highest dose levels. Marked toxicity was observed at the next lower dose level (625 µg/mL) reducing survival to 10% of the concurrent negative control value, while no toxicity was observed over the remaining dose levels.
Since the plating efficiency obtained in this experiment did not meet the acceptability criteria, a second preliminary cytotoxicity assay was performed. Taking into account the results obtained in the first experiment, the following dose levels were selected:
without S9 mix: 62.5, 31.3, 15.6, 7.81, 3.91, 1.95, 0.977, 0.488 and 0.244 µg/mL
with S9 mix: 1000, 500, 250, 125, 62.5, 31.3, 15.6, 7.81 and 3.91 µg/mL
In the absence of S9 metabolism, obvious and dose related toxicity was observed at the three highest dose levels. At 62.5 and 31.3 µg/mL survival was reduced to near the limit of detection, while at 15.6 µg/mL it was reduced to 38% of the concurrent negative control value. In the presence of S9 metabolic activation, survival was reduced to below the limit of detection at the highest dose level, while at the next lower concentration survival was 23% of the concurrent negative control value.
COMPARISON WITH HISTORICAL CONTROL DATA:
Solvent and positive control treatments were included in the mutation experiments in the absence and presence of S9 metabolism. The mutant frequwensy in the solvent control cultures fell within the normal range based on the laboratory historical control data. Marked increases were obtained with the positive control treatments indicating the correct functioning of the assay system.
ADDITIONAL INFORMATION ON CYTOTOXICITY AND MUTAGENICITY:
On the basis of the cytotoxicity results, two independent assays for mutation to 6-thioguanine resistance were performed using dose levels described below:
Experiments without S9 mix:
32.3, 23.1, 16.5, 11.8, 8.40 and 6.00 ug/mL for the first mutation assay
28.2, 21.7, 16.7, 12.8 and 9.87 ug/mL for the second mutation assay
Experiments with S9 mix:
600, 462, 355, 273, 210 and 162 ug/mL for the first mutation assay
500, 458, 382, 318 and 265 ug/mL for the second mutation assay
In the first mutation assay, following treatment in the absence of S9 metabolism, a severe toxic effect was observed at the highest dose level (32.3 ug/mL) reducing survival to 6% of the concurrent negative control value. At the next lower concentration, survival was reduced to 30%, while no relevant toxicity was observed at the remaining dose levels. In the presence of S9 metabolic activation, survival was reduced to below the limit of detection at the highest dose level of 600 ug/mL, while the two next lower concentrations (462 and 355 ug/mL) yielded 34% and 58% relative survival, respectively.
In the second mutation assay, in the absence of S9 metabolism, a severe reduction in cell survival was observed at 28.2 ug/mL (9%). At the next lower dose level (21.7 ug/mL) survival was reduced to 38% of the concurrent negative control value, while no relevant toxicity was observed at the remaining dose levels. In the presence of S9 metabolism, marked toxicity was observed at the highest dose level (5% percentage survival) while the next lower concentration (458 ug/mL) yielded 41% relative survival. No relevant toxicity was observed over the remaining dose levels.
No reproducible five-fold increases in mutant numbers or mutant frequency were observed following treatment with the test item at any dose level, in the absence or presence of S9 metabolism.
Any other information on results incl. tables
No reproducible five-fold or greater increase in mutant frequency was observed either in the absence or presence of metabolic activation at any test point. No statistically significant effect of dose level in the ANOVA analysis was observed. It is concluded that HOSTAPON TPHC does not induce gene mutation in Chinese hamster V79 cellsin vitro.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
It is concluded that HOSTAPON TPHC does not induce gene mutation in Chinese hamster V79 cells after in vitro treatment in the absence or presence of S9 metabolic activation, under the reported experimental conditions. - Executive summary:
This report describes experiments performed to assess the mutagenic activity of the test item by assaying for the induction of 6-thioguanine resistant mutants in Chinese hamster V79 cells afterin vitrotreatment (in the absence and presence of S9 metabolic activation).
The Study was performed in compliance with:
- OECD Guidelines for the testing of chemicals No. 476 (Adopted July 1997).
No reproducible five-fold or greater increase in mutant frequency was observed either in the absence or presence of metabolic activation at any test point. No statistically significant effect of dose level in the ANOVA analysis was observed.
It is concluded that HOSTAPON TPHC does not induce gene mutation in Chinese hamster V79 cellsin vitro.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.